First Time Loading...

Minerva Surgical Inc
NASDAQ:UTRS

Watchlist Manager
Minerva Surgical Inc Logo
Minerva Surgical Inc
NASDAQ:UTRS
Watchlist
Price: 0.001 USD Market Closed
Updated: May 7, 2024
Section:
 

Wall Street
Price Targets

UTRS Price Targets Summary
Minerva Surgical Inc

There are no price targets for UTRS.
UTRS Lowest Forecast
Wall Street Target
Not Available
UTRS Average Forecast
Wall Street Target
Not Available
UTRS Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Minerva Surgical Inc Competitors:
Price Targets
NVCR
Novocure Ltd
79% Upside
HTL
Hamilton Thorne Ltd
63% Upside
ECOR
electroCore, Inc.
237% Upside
G
122310
Genoray Co Ltd
504% Upside
NVCR
Novocure Ltd
79% Upside
HTL
Hamilton Thorne Ltd
63% Upside
ECOR
electroCore, Inc.
237% Upside
G
122310
Genoray Co Ltd
504% Upside
002901
Double Medical Technology Inc
53% Upside
7779
Cyberdyne Inc
62% Upside
W
336570
Won Tech Co Ltd
36% Upside
IRIX
IRIDEX Corp
27% Downside

Revenue
Forecast

Revenue Estimate
Minerva Surgical Inc

For the last 2 years the compound annual growth rate for Minerva Surgical Inc's revenue is 15%. The projected CAGR for the next 3 years is 12%.

15%
Past Growth
12%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Minerva Surgical Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Minerva Surgical Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
UTRS intrinsic value, competitors valuation, and company profile.
DCF Valuation
UTRS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
UTRS stock valuation using valuation multiples.
Wall Street Estimates
UTRS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
UTRS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is UTRS's stock price target?
Not Available

UTRS doesn't have any price targets made by Wall Street professionals.

What is Minerva Surgical Inc's Revenue forecast?
Projected CAGR
12%

For the last 2 years the compound annual growth rate for Minerva Surgical Inc's revenue is 15%. The projected CAGR for the next 3 years is 12%.

ALPHA SPREAD
Join more than 134,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.